Citius Oncology CTOR
NASDAQ CTOR
$0.70 +0.03 (+4.37%)
At close: Oct 21, 2026 · 4:00 PM EDT

Citius Oncology (CTOR) Interest Expenses (2025 - 2026)

Updated

Citius Oncology (CTOR) reported Interest Expenses of $231,732 for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 44.2% from $160,755 a year earlier and up 601.6% from the prior quarter.

Analysis

Citius Oncology (CTOR) Interest Expenses (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Citius Oncology's Interest Expenses came in at $367,881; for FY2025 (ended Sep 30, 2025), it was $218,032.

  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $33,031 (Q2 2026), $45,841 (Q1 2026) and $57,277 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 281.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 435.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 247.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Citius Oncology 72.00 Mn 41.58 Mn 1.00 Mn 231,732.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 231,732.00
Mar 31, 2026 33,031.00
Dec 31, 2025 45,841.00
Sep 30, 2025 57,277.00
Jun 30, 2025 160,755.00
API Access

Citius Oncology Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=CTOR&period=max&api_key=YOUR_API_KEY